HArmonyCa™
Hybrid injectable for lift, volume and collagen support
HArmonyCa™ is a dual-action injectable treatment combining hyaluronic acid and calcium hydroxyapatite. It is designed to address multiple signs of facial ageing in one treatment by restoring support while stimulating collagen production for firmer, tighter-looking skin over time.
It offers two complementary effects: the hyaluronic acid helps restore lost volume, while calcium hydroxyapatite supports the body’s natural collagen production.
How it works
HArmonyCa™ combines:
• HA - hyaluronic acid to help restore volume and support
• CaHA - calcium hydroxyapatite to stimulate collagen production and improve firmness over time
This makes it suitable for patients seeking a refreshed, lifted appearance without surgery.
Benefits
HArmonyCa™ may be suitable for patients who want to:
• Improve facial support and structure
• Restore lost volume
• Improve skin firmness and elasticity
• Achieve a subtle lifting effect
• Support longer-term collagen stimulation
• Refresh the face without looking overdone
A full medical consultation is required to assess suitability.
What to expect
• Pre-treatment consultation: Medical history, facial assessment and treatment planning.
• Treatment: The product is injected into carefully selected areas.
• Results: Some lifting and support may be visible quickly, with collagen-stimulating benefits developing gradually.
• Downtime: Mild swelling, bruising, tenderness or redness can occur and usually settles within days.
Areas commonly treated
• Cheeks
• Jawline
• Lower face
• Areas of facial laxity or volume loss, where clinically appropriate
FAQ
Q: Is HArmonyCa™ a filler?
A: HArmonyCa™ is a hybrid injectable. It contains hyaluronic acid for volume and calcium hydroxyapatite to support collagen production.
Q: When will I see results?
A: Some results may be seen immediately, with firmness and collagen-related improvements developing over time.
Q: Is there downtime?
A: Downtime is usually minimal, although bruising, swelling or tenderness can occur after injectable treatment.